A s we enter 2026, the global financial landscape is characterized by a "K-shaped" recovery. While public markets have surged to record highs, they remain sensitive to interest rate volatility and the disruptive potential of generative AI. For the mid-career surgeon, this creates a unique opportunity to rotate capital away from "fully valued" stocks and into the high-conviction world of Private Markets.   In 2026, the medical industry isn't just a place to work; it is a premier defensive...